FDA announces major reforms to streamline biosimilar approvals, potentially saving Americans billions on prescription drug ...
Glenmark Pharmaceuticals is set to launch an 8.4 per cent Sodium Bicarbonate Injection in the United States. This generic ...
Glenmark Pharma to launch generic Sodium Bicarbonate Injection in the US for treating metabolic acidosis. Distribution starts ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback